Skip to search formSkip to main contentSkip to account menu

BRL 42715

Known as: BRL-42715 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1997
1997
A new β-lactamase inhibitor, SYN-1012, with a penem skeleton was synthesized and its biological activity compared with clavulanic… 
1997
1997
A new beta-lactamase inhibitor, SYN-1012, with a penem skeleton was synthesized and its biological activity compared with… 
1995
1995
A new extended spectrum beta-lactamase was detected in Serratia marcescens 42039 that was isolated from urine of patients with… 
1994
1994
The interactions of Staphylococcus aureus, Bacillus cereus I, TEM, Klebsiella pneumoniae K1 and Enterobacter cloacae P99 beta… 
1993
1993
The activity of six cephalosporins, six penicillins and one monobactam combined with BRL 42715, clavulanic acid, sulbactam or… 
1993
1993
The effect of a powerful inhibitor, BRL 42715, on beta-lactamase from Shigella flexneri UCSF-129, to overcome the problem of… 
1992
1992
Ten clinical isolates and the type strain (H37Rv) of Mycobacterium tuberculosis were shown to produce an intracellular beta… 
1991
1991
BRL 42715 is a novel, highly potent beta-lactamase inhibitor with good activity against a broad range of beta-lactamases… 
1991
1991
BRL 42715 is a new penem which inhibits a wide range of plasmid as well as chromosomally mediated bacterial beta-lactamases. We…